
|Articles|June 4, 2007
Latebreakers: New drug for bacterial vaginosis
Tinidazole (Tindamax) is the first new drug for the treatment of bacterial vaginosis in 10 years and will provide a shorter course of treatment with fewer daily doses than the current standard of treatment, according to its manufacturer Mission Pharmacal.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
2
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
3
Postpartum Mothers Favor Bedtime Stopping Rule Over Stricter Chrononutrition Approaches
4
What’s Next for Pneumococcal Vaccination? An Expert Weighs In
5






























